Keywords: tekmira, expects, 2m, alnylam, canada-based, pharmaceuticals, says

Tekmira expects $11.2M from Alnylam

Article | 19 January 2009

Canada-based Tekmira Pharmaceuticals says that it expects to receive a minimum of $11.2 million over the next three years from its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in